Second attempt to withdraw cabergoline in prolactinomas: a pilot study

被引：0
|
作者：
Ratchaneewan Kwancharoen
Renata Simona Auriemma
Gayane Yenokyan
Gary S. Wand
Annamaria Colao
Roberto Salvatori
机构：
[1] Johns Hopkins University School of Medicine,Division of Endocrinology and Metabolism, Department of Medicine, Pituitary Center
[2] Johns Hopkins University School of Public Health,Department of Biostatistics
[3] University “Federico II”,Sezione di Endocrinologia, Dipartimento di Medicina Clinica e Chirurgia
来源：
Pituitary | 2014年 / 17卷
关键词：
Cabergoline; Prolactinoma; Second withdrawal; Recurrence;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：451 / 456
页数：5
相关论文
共 50 条
  • [1] Second attempt to withdraw cabergoline in prolactinomas: a pilot study
    Kwancharoen, Ratchaneewan
    Auriemma, Renata Simona
    Yenokyan, Gayane
    Wand, Gary S.
    Colao, Annamaria
    Salvatori, Roberto
    PITUITARY, 2014, 17 (05) : 451 - 456
  • [2] Prolactin Response to Metformin in Cabergoline-Resistant Prolactinomas: A Pilot Study
    Correa Portari, Luiz Henrique
    Correa-Silva, Silvia Regina
    Abucham, Julio
    NEUROENDOCRINOLOGY, 2022, 112 (01) : 68 - 73
  • [3] Cabergoline in prolactinomas
    Fierz, AB
    Kaufman, DI
    Lee, AG
    Eggenberger, ER
    Friend, KE
    NEURO-OPHTHALMOLOGY, 1999, 22 (01) : 37 - 46
  • [4] Prolactinomas, cabergoline, and pregnancy
    Andrea Glezer
    Marcello D. Bronstein
    Endocrine, 2014, 47 : 64 - 69
  • [5] Prolactinomas, cabergoline, and pregnancy
    Glezer, Andrea
    Bronstein, Marcello D.
    ENDOCRINE, 2014, 47 (01) : 64 - 69
  • [6] Cabergoline and quinagolide therapy for prolactinomas
    Webster, J
    CLINICAL ENDOCRINOLOGY, 2000, 53 (05) : 549 - 550
  • [7] Cabergoline Resistance in Pediatric Prolactinomas
    Spinks, Joanne J.
    Ryan, Fiona J.
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2009, 31 (05) : 377 - 379
  • [8] Effect of Cabergoline on Metabolism in Prolactinomas
    Auriemma, Renata S.
    Granieri, Luciana
    Galdiero, Mariano
    Simeoli, Chiara
    Perone, Ylenia
    Vitale, Pasquale
    Pivonello, Claudia
    Negri, Mariarosaria
    Mannarino, Teresa
    Giordano, Carla
    Gasperi, Maurizio
    Colao, Annamaria
    Pivonello, Rosario
    NEUROENDOCRINOLOGY, 2013, 98 (04) : 299 - 310
  • [9] Dopamine agonists in prolactinomas: when to withdraw?
    Pedro Souteiro
    Sandra Belo
    Davide Carvalho
    Pituitary, 2020, 23 : 38 - 44
  • [10] Dopamine agonists in prolactinomas: when to withdraw?
    Souteiro, Pedro
    Belo, Sandra
    Carvalho, Davide
    PITUITARY, 2020, 23 (01) : 38 - 44
12345